Q301--Notice Of Intent To Sole Source Natera Transplant Rejection Surveillance
The scope, dates and status of this tender. A free account opens every field.
Source: SAM.gov
In accordance with RFO 12.201-1, this Notice of Intent is to inform all parties the Department of Veterans Affairs, Network Contracting Office (NCO) 19 located at 6162 South Willow Drive Suite 300, Greenwood Village, CO 80111 intends to award a sole source procurement for the following requirement to the large business, Natera, Inc., located at 13011 McCallen Pass, Austin, Texas 78752: ITEM # DESC
- Status
- Prospective
- Sector
- Residential, Hospital, Government, Commercial
- Location
- United States of America
- Updated
- 3 Nov 2026
- Source
- SAM.gov
ConstructChat
Ask ConstructChat about Q301--Notice Of Intent To Sole Source Natera Transplant Rejection Surveillance
Pick a question to edit it, or write your own.
First answer free · no account
Tender Information FAQ
Tender Information
Participants
| Not available for this record. |
Status
Original status | special notice |
Taiyo status | Prospective |
Taiyo last update | 2026-11-03 |
Contact
| Not available for this record. |
Description
Description | In accordance with RFO 12.201-1, this Notice of Intent is to inform all parties the Department of Veterans Affairs, Network Contracting Office (NCO) 19 located at 6162 South Willow Drive Suite 300, Greenwood Village, CO 80111 intends to award a sole source procurement for the following requirement to the large business, Natera, Inc., located at 13011 McCallen Pass, Austin, Texas 78752: ITEM # DESCRIPTION OF SUPPLIES QTY UNIT OF ISSUE 0001 Molecular expression transplant assessment testing 225 EA 0002 Molecular Assessment for Kidney Disease 15 EA 0003 Molecular Genetic Prenatal Screening Test 20 EA Natera Inc. is the sole source for the requested molecular genetic reference testing as the testing is proprietary to Natera. This acquisition will provide reference testing for Natera s Prospera molecular expression transplant assessment testing, Renasight molecular assessment for kidney disease, and Panorama Noninvasive prenatal test (NIPT) molecular genetic prenatal screening tests. The associated North America Classification Systems (NAICS) Code is 621511 and the Business Size Standard is $41.5 Million. THIS NOTICE OF INTENT IS NOT A REQUEST FOR COMPETITIVE QUOTES. Interested parties may identify their interest and capability to respond to this requirement no later than 3:00 PM Mountain Standard Time, Wednesday, August 19th, 2026. Information received in response to this notice must clearly demonstrate the capability of meeting the Government s need as stated above. Include any relevant information (specifications, cut sheets, brochures, capability statement, etc.) confirming the ability to supply the products and/or any services outlined in this notice. Responses to this notice are to be sent to Lindsey.Zwaagstra@va.gov. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government. The Government is not responsible for any potential costs incurred from interested parties desiring to respond to this notice. |
Original sector | Health Care and Social Assistance |
Location
Country | United States of America (USA) |
Source
Source | SAM.gov |
URL |
More Details
Record type | Tender |
Sector | Residential, Hospital, Government, Commercial |
Article published date | 2026-08-13 |
Research
Free account
View all details
You are reading the public part. A free account opens the rest:
- Every detail on this tender
- News and media coverage
- Technical research
Free account · no card · lands you back on this tender
